PIII Stock Soars As Earnings Beat Signals Turnaround

P3 Health Partners Inc. surged as transformative healthcare expansion news fueled bullish sentiment; stocks have been trading up by 99.13 percent

Live Update At 10:02:40 EDT: On Friday, May 15, 2026 P3 Health Partners Inc. stock [NASDAQ: PIII] is trending up by 99.13%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

PIII just delivered the kind of move that gets traders’ attention. The stock had been grinding around the high-$2s to low-$3s for weeks. Then the Q1 2026 earnings hit on 2026/05/14, and P3 Health Partners ripped from a $4.03 close to $8.03 the next day — a near double in one session.

Under the hood, P3 Health Partners posted Q1 revenue of $386M, up from $373M a year ago. That’s modest top-line growth, but the real story is the profit swing. EPS jumped to $0.32 from a brutal $6.28 loss. Adjusted EBITDA landed near $26M, and GAAP net income turned positive at about $1.2M, versus a big loss last year.

More Breaking News

• BBAI Stock Steadies As BigBear.ai Builds Defense AI Momentum
• DexCom Stock Draws Bullish Targets As Governance Shifts
• Celcuity Stock Surges As Gedatolisib Data Ignites Wall Street
• SLE Stock Jumps As Misfits Ads Deal Targets Profitability

On a trailing basis, many ratios still scream “distressed.” PIII shows negative book value around -$144.9M and heavy debt of roughly $270.4M, with a thin current ratio near 0.2. But the new quarter changes the trajectory. For momentum traders, that sharp profitability inflection — paired with a multi-day breakout from sub-$3 to over $8 — signals a name where sentiment just flipped from survival mode to turnaround story.

Why Traders Are Watching PIII Now

This Q1 print is exactly the kind of earnings surprise that can reset a chart and a whole narrative. P3 Health Partners had spent two years restructuring and cleaning up operations. Now the numbers finally show it. EPS at $0.32 versus a $6.28 loss is not a small tweak — it’s a full regime change for PIII.

The company generated about $26M in adjusted EBITDA in Q1 and raised full-year 2026 adjusted EBITDA guidance to a midpoint around $40M. That means management expects the rest of the year to stay profitable, even after cutting at-risk membership by 10% to reduce exposure to loss-making contracts. For traders, that signals discipline: PIII is walking away from bad revenue and still guiding to stronger earnings.

Guidance for FY26 revenue of $1.5B–$1.65B, with $20M–$60M in adjusted EBITDA, shows the growth story is intact. Top line is expected to keep climbing while margins turn positive, though still slim. That combination — growing sales plus a fresh turn to profitability — is exactly the mix that can fuel multi-day runs as shorts cover and latecomers chase.

Balance sheet work adds another catalyst. The Debt Exchange Agreement with Chicago Pacific Founders is aimed at boosting stockholders’ equity and regaining compliance with Nasdaq’s Listing Rule 5550(b)(1). That directly addresses delisting fears, a major overhang for any small-cap. When traders see both earnings momentum and listing risk being handled, they often re-rate the entire story.

On the tape, the intraday action on 2026/05/15 shows clean momentum. PIII gapped from around $5.19 at the open, pushed through $6, then squeezed to an $8.38 high before closing at $8.03. That’s classic earnings-breakout behavior on a low-float-style chart, with prior days stuck in the $2.50–$4.00 range. Active traders will watch to see if $7–$7.50 holds as a new support zone on any pullbacks.

Conclusion

For active traders, PIII just transitioned from a forgotten healthcare name to a live momentum candidate. P3 Health Partners backed up the chart with real numbers: revenue up to $386M, adjusted EBITDA around $26M, and an EPS swing deep into the green. Forward guidance calling for up to $1.65B in revenue and as much as $60M in adjusted EBITDA tells you management sees this as the start of a new phase, not a one-off quarter.

At the same time, the capital structure still matters. Negative equity, heavy debt, and weak liquidity ratios remain real risks. That is why the Debt Exchange Agreement with Chicago Pacific Founders and the goal of regaining Nasdaq equity compliance are key parts of the PIII thesis for traders who care about headline risk and potential dilution. This is exactly the kind of situation where trade selection and risk management become critical. As Tim Bohen, lead trainer with StocksToTrade says, “A good trade setup checks all the boxes—volume, trend, catalyst. Don’t trade if you’re missing pieces of the puzzle.” For anyone considering PIII, that means weighing the momentum and guidance against the balance-sheet overhang before taking a trading position.

The price action speaks to how the market digested all of this. A move from roughly $3–$4 into the $8 zone in a day shows just how violently sentiment can flip once a beaten-down stock like P3 Health Partners proves it can make money. This is where trader discipline comes in. As Tim Sykes likes to say, “The market doesn’t care about your opinion, only your preparation and your rules.” For anyone watching PIII, that means studying the levels, respecting the volatility, and staying data-driven — not emotional — as this turnaround story plays out.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

• How to Read Stock Charts: A Guide for Beginners
• Trading Plan: 6 Steps to Create One
• How To Create a Stock Watchlist

Ready to build your watchlists? Check out these curated lists:

• AI Penny Stocks
• Robinhood Penny Stocks
• Top Biotech Stocks

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.